Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
German start-up Verovaccines will further develop its pipeline at a new R&D facility in Halle.
Royal DSM aims to continue outperforming the global animal nutrition market through gut health innovation, geographic expansion and M&A in the premix area.
Denmark's leading aquaculture feed company BioMar has improved its domestic hatchery research capabilities.
The Kansas City Area Life Sciences Institute (KCALSI) is to be renamed BioNexus KC – a rebranding that highlights the organization's work in both animal and human health.
Boehringer Ingelheim has continued to develop its network of vaccine capabilities by spending over €200 million ($235 million) to establish a new vaccine production center in France.
Phibro Animal Health plans to establish a new vaccine production facility in Sligo, Ireland.
Ceva Santé Animale has strengthened its presence in the sub-Saharan Africa market by securing Olam Hatcheries as a partner.
US animal health firm Zomedica Pharmaceuticals has effected an interim closing and announced an extension of its private offering.
Zoetis aims to improve reactions to new outbreaks through the establishment of the Center for Transboundary and Emerging Diseases.
Brazil's NGS Soluções Genômicas wants to take its mastitis diagnostics to international markets through distribution partners.
UK aquaculture health company Benchmark posted a sales increase of 9% for the first half of 2018.
US veterinary diagnostics company expects to grow its annual revenues by around 13.5% per year through 2022.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.